Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.2M Sell
100,231
-6,406
-6% -$1.57M 0.09% 121
2025
Q4
$27M Sell
106,637
-1,963
-2% -$493K 0.11% 116
2025
Q3
$26.9M Sell
108,600
-3,281
-3% -$785K 0.11% 118
2025
Q2
$26.9M Sell
111,881
-1,587
-1% -$370K 0.12% 118
2025
Q1
$25.7M Sell
113,468
-4,460
-4% -$981K 0.12% 114
2024
Q4
$24.2M Sell
117,928
-6,068
-5% -$1.33M 0.12% 119
2024
Q3
$30.1M Sell
123,996
-5,468
-4% -$1.28M 0.15% 107
2024
Q2
$28.4M Buy
129,464
+1,659
+1% +$360K 0.15% 105
2024
Q1
$28.7M Buy
127,805
+21,706
+20% +$4.9M 0.17% 104
2023
Q4
$23.3M Buy
106,099
+4,917
+5% +$1.04M 0.15% 112
2023
Q3
$22.2M Buy
101,182
+2,616
+3% +$592K 0.16% 111
2023
Q2
$22.2M Buy
98,566
+391
+0.4% +$78.2K 0.21% 100
2023
Q1
$18.8M Sell
98,175
-1,601
-2% -$309K 0.19% 105
2022
Q4
$18.4M Buy
99,776
+13,279
+15% +$2.33M 0.21% 100
2022
Q3
$14.4M Buy
86,497
+17,320
+25% +$3.52M 0.18% 108
2022
Q2
$14.3M Buy
+69,177
New +$15.6M 0.16% 112

Other funds holding STE

Rathbones Group's STE Position: Q1 2026 in Review

Rathbones Group reduced its Steris (STE) stake by 6% in Q1 2026, selling an estimated $1.57M and leaving 100,231 shares worth $22.2M. The position accounts for 0.09% of the portfolio, ranked #121.

Rathbones Group first reported a position in STE in Q2 2022 and has held it in 16 quarters since. The position peaked at $30.1M in Q3 2024. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Rathbones Group held 100,231 shares of Steris worth $22.2M as of Q1 2026.
  • Rathbones Group sold 6,406 Steris shares in Q1 2026, an estimated $1.57M.
  • Steris made up 0.09% of Rathbones Group's portfolio in Q1 2026, its #121 holding.
  • Rathbones Group first reported a position in Steris in Q2 2022 and has held it in 16 quarters since.
  • Rathbones Group's Steris position peaked at $30.1M in Q3 2024.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Rathbones Group's 13F filing for Q1 2026, filed 12 May 2026.